NAD+ 500 mg, glass vial, crimp seal, flip-top cap, California Standard Peptides label

Research compounds

NAD+

NAD+ (nicotinamide adenine dinucleotide) is an endogenous coenzyme, not a peptide. It is central to cellular energy metabolism, and tissue NAD+ levels have been reported to decline with age in rodents and humans.

500 mgCS-NAD-500$100.00
1000 mgCS-NAD-1000$210.00
Choose a size and add to cart →
Container
Glass vial, crimp seal, flip-top cap
Storage
-20 °C, desiccated, protect from light
Paperwork
Lot certificate (HPLC + mass spec) shown before you pay

Lot certificates

You’ll see American Peptides on the lab’s copy. They’re our supplier.

  • 500 mg, lot NAD500-0803: 99.78% purity (RP-HPLC), 503.42 mg measured, identity confirmed by mass spec. Issued 2026-08-28 by Bioviridian Inc.. Verify certificate COA7592
  • 1000 mg, lot NAD1000-0803: 99.74% purity (RP-HPLC), 1004.23 mg measured, identity confirmed by mass spec. Issued 2026-08-28 by Bioviridian Inc.. Verify certificate COA7611

Our vials are filled from lots made by our supplier, American Peptides, and tested by Bioviridian Inc.The laboratory’s original certificate lists American Peptides as the vendor. Look up the code at bioviridians.com to check it.

What researchers study it for

  • Cellular redox and energy metabolism
  • Sirtuin, PARP, and CD38 biology
  • Age-related NAD+ decline
  • NAD+ precursors in human trials
  • Muscle and vascular function in older adults

How it is thought to work

NAD+ acts as a coenzyme that carries electrons in redox reactions of energy metabolism. It is also consumed as a substrate by non-redox enzymes including sirtuins, poly(ADP-ribose) polymerases (PARPs), and CD38, linking it to DNA repair, chromatin regulation, and immune cell function. Many human studies of raising NAD+ have used oral precursors such as nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) rather than NAD+ itself.

Where the research stands

Endogenous metabolite; investigational. NAD+ is not an FDA-approved drug for any indication, and small randomized trials of precursors show raised NAD+ metabolites but mixed functional results, including no significant muscle benefit in a 2025 meta-analysis of older adults.

Sources

  1. Covarrubias AJ, Perrone R, Grozio A, Verdin E (2021). NAD(+) metabolism and its roles in cellular processes during ageing.. Nature Reviews Molecular Cell Biology.
  2. Rajman L, Chwalek K, Sinclair DA (2018). Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence.. Cell Metabolism.
  3. Martens CR, Denman BA, Mazzo MR, Armstrong ML, Reisdorph N, McQueen MB, Chonchol M, Seals DR (2018). Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD(+) in healthy middle-aged and older adults.. Nature Communications.
  4. Prokopidis K, Moriarty F, Bahat G, McLean J, Church DD, Patel HP (2025). The Effect of Nicotinamide Mononucleotide and Riboside on Skeletal Muscle Mass and Function: A Systematic Review and Meta-Analysis.. Journal of Cachexia, Sarcopenia and Muscle.

Read more

For laboratory research use only. Not a drug, food, supplement or cosmetic; not for human or veterinary use. Nothing on this page is medical advice or a usage guide.

California Standard Peptides

Your cart

0 items · free shipping over $200.00

Your cart is empty.

Buy 2 of a vial and save 10%, 3 and save 15%. Research sets are 15% off, and shipping is free over $200.00.

First order

20% off your first order.

Join the list for first word on new lots, restocks and member pricing. Your code arrives by email and applies by itself at checkout.

One code per email, for your first order. By signing up you agree to get emails from us. Unsubscribe anytime.

For laboratory research use only. 21+.